Plain-English translation of NCT07938333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Researchers want to understand how vitamin D affects the bacteria living in your child's gut when they are first diagnosed with acute lymphoblastic leukemia. The study will collect stool samples at key points during early chemotherapy treatment to see if vitamin D levels influence which bacteria are present and how well the gut is functioning. This information could help doctors better support children's health during cancer treatment.
Cancer treatment can disrupt the healthy bacteria in a child's digestive system, which may affect their overall wellbeing. Vitamin D is known to play a role in immune function and gut health, but researchers don't yet understand exactly how vitamin D status influences the gut bacteria of children being treated for leukemia. This study aims to fill that gap so doctors can consider vitamin D as part of supportive care.
You likely qualify if…
You likely don't qualify if…
Your child will provide stool samples at three time points: within a few days of starting chemotherapy, at the end of the initial induction phase (around day 29–32), and again about 90–97 days after starting treatment. If your child's vitamin D levels are low, the oncology team will provide vitamin D supplementation as part of standard care. The stool samples will be tested to understand the gut bacteria and other compounds present. The entire study spans roughly three months.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
United States